U.S. flag

An official website of the United States government

Format

Send to:

Choose Destination
    • Showing Current items.

    FBLN5 fibulin 5 [ Homo sapiens (human) ]

    Gene ID: 10516, updated on 3-Apr-2024

    GeneRIFs: Gene References Into Functions

    GeneRIFPubMed TitleDate
    FBLN5 was Regulated by PRDM9, and Promoted Senescence and Osteogenic Differentiation of Human Periodontal Ligament Stem Cells.

    FBLN5 was Regulated by PRDM9, and Promoted Senescence and Osteogenic Differentiation of Human Periodontal Ligament Stem Cells.
    Zhao M, Rong R, Zhang C, Yang H, Han X, Fan Z, Zheng Y, Zhang J., Free PMC Article

    01/12/2024
    Genetic screening for anticancer genes highlights FBLN5 as a synthetic lethal partner of MYC.

    Genetic screening for anticancer genes highlights FBLN5 as a synthetic lethal partner of MYC.
    Masood M, Ding Q, Cawte AD, Rueda DS, Grimm SW, Yagüe E, El-Bahrawy M., Free PMC Article

    11/3/2023
    Genetic variants and haplotypes in fibulin-5 (FBLN5) are associated with pseudoexfoliation glaucoma but not with pseudoexfoliation syndrome.

    Genetic variants and haplotypes in fibulin-5 (FBLN5) are associated with pseudoexfoliation glaucoma but not with pseudoexfoliation syndrome.
    Kapuganti RS, Bharati B, Mohanty PP, Alone DP., Free PMC Article

    03/10/2023
    Decreased Expression of EC-SOD and Fibulin-5 in Alveolar Walls of Lungs From COPD Patients.

    Decreased Expression of EC-SOD and Fibulin-5 in Alveolar Walls of Lungs From COPD Patients.
    García-Valero J, Olloquequi J, Rodríguez E, Martín-Satué M, Texidó L, Ferrer J.

    06/18/2022
    Knockdown of ubiquitin-conjugating enzyme E2T (UBE2T) suppresses lung adenocarcinoma progression via targeting fibulin-5 (FBLN5).

    Knockdown of ubiquitin-conjugating enzyme E2T (UBE2T) suppresses lung adenocarcinoma progression via targeting fibulin-5 (FBLN5).
    Li Y, Yang X, Lu D., Free PMC Article

    05/14/2022
    MiR-552-3p facilitated cell proliferation, migration and invasion by sponging Fibulin 5 in non-small cell lung cancer via activation of ERK/GSK3beta/beta-catenin signaling pathway.

    MiR-552-3p facilitated cell proliferation, migration and invasion by sponging Fibulin 5 in non-small cell lung cancer via activation of ERK/GSK3β/β-catenin signaling pathway.
    Huang M, Liao X, Li L, Li G, Chen M.

    03/5/2022
    PAD2-mediated citrullination of Fibulin-5 promotes elastogenesis.

    PAD2-mediated citrullination of Fibulin-5 promotes elastogenesis.
    Sun B, Tomita B, Salinger A, Tilvawala RR, Li L, Hakami H, Liu T, Tsoyi K, Rosas IO, Reinhardt DP, Thompson PR, Ho IC., Free PMC Article

    01/22/2022
    Demyelinating Charcot-Marie-Tooth neuropathy associated with FBLN5 mutations.

    Demyelinating Charcot-Marie-Tooth neuropathy associated with FBLN5 mutations.
    Safka Brozkova D, Stojkovic T, Haberlová J, Mazanec R, Windhager R, Fernandes Rosenegger P, Hacker S, Züchner S, Kochański A, Leonard-Louis S, Francou B, Latour P, Senderek J, Seeman P, Auer-Grumbach M.

    08/14/2021
    FBLN5 is targeted by microRNA27a3p and suppresses tumorigenesis and progression in highgrade serous ovarian carcinoma.

    FBLN5 is targeted by microRNA‑27a‑3p and suppresses tumorigenesis and progression in high‑grade serous ovarian carcinoma.
    Li R, Wu H, Jiang H, Wang Q, Dou Z, Ma H, Yan S, Yuan C, Yang N, Kong B., Free PMC Article

    07/24/2021
    Fibulin-5 protects the extracellular matrix of chondrocytes by inhibiting the Wnt/beta-catenin signaling pathway and relieves osteoarthritis.

    Fibulin-5 protects the extracellular matrix of chondrocytes by inhibiting the Wnt/β-catenin signaling pathway and relieves osteoarthritis.
    Gao JB, Lin L, Men XQ, Zhao JB, Zhang MH, Jin LP, Gao SJ, Zhao SQ, Dong JT.

    04/3/2021
    Network-based analysis reveals novel gene signatures in the peripheral blood of patients with sporadic nonsyndromic thoracic aortic aneurysm.

    Network-based analysis reveals novel gene signatures in the peripheral blood of patients with sporadic nonsyndromic thoracic aortic aneurysm.
    Xu H, Chen S, Zhang H, Zou Y, Zhao J, Yu J, Le S, Cui J, Jiang L, Wu J, Xia J.

    12/19/2020
    Identification of pelvic organ prolapse risk susceptibility gene SNP locus in Xinjiang women.

    Identification of pelvic organ prolapse risk susceptibility gene SNP locus in Xinjiang women.
    Abulaizi A, Abula A, Ababaikeli G, Wan X, Du R, Zhakeer A.

    12/5/2020
    Fibulin-5 contributes to colorectal cancer cell apoptosis via the ROS/MAPK and Akt signal pathways by downregulating transient receptor potential cation channel subfamily V member 1.

    Fibulin-5 contributes to colorectal cancer cell apoptosis via the ROS/MAPK and Akt signal pathways by downregulating transient receptor potential cation channel subfamily V member 1.
    Chen Y, Li J, Jin L, Lei K, Liu H, Yang Y.

    09/12/2020
    Evaluation of the fibulin 5 gene polymorphism as a factor related to the occurrence of pelvic organ prolapse.

    Evaluation of the fibulin 5 gene polymorphism as a factor related to the occurrence of pelvic organ prolapse.
    Paula MVB, Lira Júnior MAF, Monteiro VCESC, Souto RP, Fernandes CE, Oliveira E.

    09/5/2020
    This study unravels two novel risk variants within FBLN5 gene in the pathogenesis of pseudoexfoliation (PEX). Further, a decreased expression of FBLN5 in PEXS affected lens capsules implicates a pathogenic link between extracellular matrix maintenance and onset of PEX.

    De novo variants in an extracellular matrix protein coding gene, fibulin-5 (FBLN5) are associated with pseudoexfoliation.
    Padhy B, Kapuganti RS, Hayat B, Mohanty PP, Alone DP., Free PMC Article

    07/18/2020
    Fibulin-1 and -5 measurements might be used to exclude non-ST-elevation myocardial infarction (NSTEMI) in patients admitted to the emergency department with acute chest pain.

    Fibulin‑1 and fibulin‑5 as rule‑out tests for non-ST‑elevation myocardial infarction in the emergency setting.
    Zencir C, Sivri F, Gulasti S, Turkdogan AK, Yilmaz M, Gungor H.

    06/20/2020
    NOX1 and Fibulin-5 were increased and decreased in aortic dissection, respectively. NOX1 is a negative modulator of Fibulin-5.

    NOX1 Negatively Modulates Fibulin-5 in Vascular Smooth Muscle Cells to Affect Aortic Dissection.
    Hu X, Jiang W, Wang Z, Li L, Hu Z.

    02/1/2020
    Fibulin-5 is down-regulated in CRC and the reduced expression of fibulin-5 was correlated with malignant clinicopathological characteristics.

    Fibulin-5 is Down-Regulated in Colorectal Cancer and Correlated with Clinicopathologic Characteristics.
    Chen Z, Wang Z, Chen J, Li Z.

    09/14/2019
    Fibulin-5 silencing in non-small-cell lung cancer cells is due to the hypermethylation of its promoter through 2-hydroxyglutarate, production of which arises from a mutation in IDH1.

    IDH1 mutation promotes lung cancer cell proliferation through methylation of Fibulin-5.
    Yan B, Hu Y, Ma T, Wang Y., Free PMC Article

    07/20/2019
    We describe a novel, homozygous c.518A>G, p.R173H mutation in exon 6 of the FBLN5 gene, confirming the diagnosis of autosomal recessive cutis laxa.

    Autosomal recessive cutis laxa: a novel mutation in the FBLN5 gene in a family.
    Tekedereli I, Demiral E, Gokce IK, Esener Z, Camtosun E, Akinci A.

    06/15/2019
    study reports the first Chinese family with c.1117C>T mutation of FBLN5; findings confirm a novel subtype of autosomal-dominant Charcot-Marie-Tooth disease due to a mutation in the FBLN5 gene

    Adult-onset demyelinating neuropathy associated with FBLN5 gene mutation.
    Cheng S, Lv H, Zhang W, Wang Z, Shi X, Liang W, Yuan Y., Free PMC Article

    09/29/2018
    The results showed a significant upregulation of ECM1 and ITGB3, and a significant downregulation for FBLN5 in pelvic organ prolapse patients.

    Expression of extracellular matrix and adhesion proteins in pelvic organ prolapse.
    Cecati M, Corradetti A, Sartini D, Pozzi V, Giannubilo SR, Saccucci F, Ciavattini A, Emanuelli M.

    09/22/2018
    Serum fibulin-5 concentration can be regarded as a biomarker for evaluating disease severity and predicting prognosis in intracerebral hemorrhage patients.

    Fibulin-5: a novel biomarker for evaluating severity and predicting prognosis in patients with acute intracerebral haemorrhage.
    Hu L, Dong MX, Zhao H, Xu GH, Qin XY.

    01/13/2018
    Fibulin-5 expression is increased in the induced sputum of asthmatic patients.

    Fibulin-5 promotes airway smooth muscle cell proliferation and migration via modulating Hippo-YAP/TAZ pathway.
    Fu J, Zheng M, Zhang X, Zhang Y, Chen Y, Li H, Wang X, Zhang J.

    10/21/2017
    Data show that fibulin-5 strongly binds to the endothelial cell surface reducing endothelial cell viability and interfering with the signaling pathways of the Ang-1/TIE-2 receptor axis.

    Fibulin-5 Regulates Angiopoietin-1/Tie-2 Receptor Signaling in Endothelial Cells.
    Chan W, Ismail H, Mayaki D, Sanchez V, Tiedemann K, Davis EC, Hussain SN., Free PMC Article

    07/22/2017
    firstprevious page of 4 nextlast